Intravoxel incoherent motion is a potential non-invasive diagnostic tool in brain tumours, without any clear guidelines for its evaluation yet. In our study, we compare intravoxel incoherent motion with dynamic susceptibility contrast magnetic resonance imaging in the quantification of tumour tissue blood perfusion in 28 patients affected by brain tumours, highlighting the issues encountered during the acquisition set-up and post-processing steps. Intravoxel incoherent motion is a new imaging tool and an alternative technique to dynamic susceptibility contrast-magnetic resonance imaging which is of considerable interest at present. This is partly because it does not require the use of a contrast agent and relies on the intrinsic properties of motion in the capillaries of the spins. Compared to dynamic susceptibility contrast-magnetic resonance imaging, the intravoxel incoherent motion technique is also characterised by better resolution because the gadolinium-based contrast agent bolus used in the standard technique results in a variation by more than 50% of the signal coming from the brain. Finally, intravoxel incoherent motion is more sensitive to the incoherent motion that originates from small capillary vessels, while the dynamic susceptibility contrast signal is also contaminated by the input from larger arteries and veins, which may result in an overestimation of the blood volume. Although there are limitations due to the heterogeneity of the sample considered in our study, intravoxel incoherent motion has been shown to be an accurate noninvasive radiological biomarker, useful to distinguish between low and high grade glial tumours.
Introduction
Gliomas are the most common primitive brain tumours that originate from glial cells: astrocytes, oligodendrocytes and ependymocytes. The World Health Organization (WHO) defines four grades of malignancy based on their histopathological characteristics: low grade gliomas (LGGs; grades I-II) and high-grade gliomas (HGGs; grades III-IV). 1 Defining the correct grade of a glioma is critical for planning a therapeutic strategy and establishing a prognosis.
The current management of LGGs is somewhat controversial: either a conservative strategy of the type 'watch and wait', or a more radical approach with the use of chemotherapy and radiotherapy in a single or combined mode is adopted, until a surgical option is required. 2, 3 In contrast, HGGs require, if possible, more radical surgery in combination with chemotherapy and radiotherapy in patients under the age of 70 years, while less invasive treatments based on biopsy and/or partial resection of the tumour along with a course of radiotherapy are adopted in patients over the age of 70 years. 4, 5 The current standard criterion for determining the tumour grading is based on histological evaluation, but it has two major limitations. The first is that it is an invasive procedure, the second is that the sampling of the entire lesion is not always possible. Thus, a biopsy or a partial excision of the tumour may lead to an underestimation of grading, with important implications for the management of the patient. 6 Magnetic resonance imaging (MRI) has a leading role in the diagnosis and preoperative grading of brain tumours and is also an important evaluation asset during and after radio-and chemotherapy. Conventional MRI techniques, with and without contrast, are an essential tool for the characterisation of cancers even if they are unable to obtain images with good specificity in defining tumour grading and identifying those subclasses of cancers with worse prognoses.
For this reason, over the past 20 years several advanced magnetic resonance (MR) techniques have been introduced alongside conventional ones to obtain additional functional, micro-structural and biochemical information on brain lesions: from DWI (diffusionweighted imaging) and PWI (perfusion weighted imaging) to MRS (magnetic resonance spectroscopy). [7] [8] [9] [10] Currently, the study of brain tumours is based on the combined evaluation of both methods, standard and advanced, with a qualitative and semi-quantitative analysis of parameters obtained from the latter. However, even these techniques have not demonstrated sufficiently high sensitivity and specificity in distinguishing high and low grade tumours and pose specific problems. 11, 12 Intravoxel incoherent motion (IVIM) is an evolution of diffusion studies, which has recently been applied to brain lesion studies; in fact, this method was developed during the middle 1980s by LeBihan et al. to evaluate quantitatively all types of microscopic translational motions occurring in a given voxel.
13,14

IVIM analysis
An alternative method for assessing the micro-perfusion tissue of brain tumours had already been proposed by LeBihan in 1986.
14 Le Bihan hypothesised that as the reduction in the MR signal observed in the diffusion-weighted sequences was not an event exclusively linked to molecular diffusion motions, it also depended on other incoherent motions that normally occur in a voxel, including those due to the flow of blood in the capillaries. He named these motions as IVIM to emphasize their random nature, just like Brownian motions.
The microcirculation of blood normally occurs within a network of capillaries with more or less variable geometry which, however, does not have a preferred orientation, thus simulating the microscopic phenomena of diffusion in its pathway, although on a larger scale of measurement. Consequently, it can also be referred to as 'macro-diffusion' and the coefficient of pseudo-diffusion D* has been introduced which describes this new entity. However, the MR signal is also affected by the presence within the same voxel of other flows in addition to blood flow, such as that of cerebrospinal fluid (CSF). Because of these additional components, the values of the apparent diffusion coefficient (ADC) detectable in tissues in vivo can be higher than pure-water diffusion coefficients. Therefore, the ADC will be a function of both the diffusion coefficient of the static tissue component and the fractional volume (f) of active capillaries in the tissue, as well as depending on the turbulent or laminar flow possibly present within the same voxel. 14 The objective of IVIM is essentially to generate combined and/or separate images of the diffusion coefficient D and of the perfusion factor f. The perfusion images are thus images of the active capillary density, that is, those in which the blood flows normally. 15 
Materials and methods Population
The study enrolled 39 patients with tumours of the glial series in the first diagnostic stage, during follow-up after biopsy or partial removal, and/or receiving chemotherapy and radiotherapy. The population was composed of 25 males and 14 females, with a mean age of 56.4 AE 11 years (ranging between 36-73 years).
From June 2014-March 2015, all patients underwent MRI on 3 Tesla equipment. Each lesion had already a definitive histological diagnosis. The tumour grading of each lesion was determined according to the WHO criteria of classification of central nervous system tumours, 2007. 16 Written informed consent was obtained from each patient included in our study and Ethical Committee approval was granted.
MRI acquisition protocols
MRI studies were performed on a 3-Tesla unit (Signa Excite, GE Medical System, Milwaukee, Wisconsin, USA) using an eight-channel sensitivity encoding head coil.
Protocol used for morphological examination. This was as follows: sagittal and axial spin-echo (SE) T1-weighted imaging repetition time (TR) 560 ms, echo time (TE) 18 ms, number of excitations (NEX) 2; field of view (FOV) 24 cm, matrix 384 Â 224; slice thickness 4 mm); axial fluid-attenuated inversion recovery (FLAIR) T2-weighted (TR 9002 ms, TE 91 ms; NEX 2; FOV 24 cm; matrix 30 Â 320; slice thickness 4 mm); axial fast spinecho (FSE) T2-weighted (TR 4200 ms; TE 93 ms; NEX 2; FOV 24 cm; matrix 512 Â 512; slice thickness 4 mm).
Post-contrast T1-weighted imaging. This was as follows (Magnevist Schering or Dotarem Guerbet 0.2 mmmol/kg): SE T1-weighted (TR 560 ms; TE 18 ms, NEX 2; FOV 24 cm; matrix 384 Â 224; slice thickness 4 mm) in three orthogonal directions. On the basis of the morphological examination, the presence or absence of pathological impregnation and of necrotic/ cystic areas within the lesion was determined for each patient. We then used the specific processed plug-in for IVIM processing with bi-exponential analysis of DWI sequences, tracing the focus areas manually (region of interest (ROI)) with dimensions between 27-30 mm 2 , in areas with a higher fraction of perfusion on IVIM maps, avoiding cystic/necrotic areas and subarachnoid spaces, a possible source of artefacts in the reported values. To ensure the correct identification of the test to be used, the distribution of values of f-IVIM and relative cerebral blood volume (rCBV) for both groups of low and high grade tumour lesions was verified; in view of the reduced size of the case sample, it was then decided to apply the Mann-Whitney one-tailed test assuming that there was a statistically significant difference between the two groups if the calculated p < 0.05.
IVIM-MRI.
Statistical analysis
The Pearson r coefficient was also calculated to determine whether there was a correlation between the fraction of perfusion f of IVIM and rCBV of the dynamic susceptibility contrast (DSC)-MRI.
Results
Of the 39 patients studied, seven were excluded because they had no evidence of residual tumour at the time of imaging and another four were discarded because, for technical reasons, it was not possible to reconstruct the IVIM or DSC-MRI perfusion maps. The lesions of the remaining 28 patients were then divided into two groups:
1. Six low-grade lesions (grade II according to the WHO classification) of which three were astrocytomas, two were oligodendrogliomas, one was an oligoastrocytoma. 2. Twenty-two high-grade lesions (grade III and IV according to WHO) including one anaplastic oligodendroglioma, two grade III anaplastic astrocytomas and 19 grade IV multiform glioblastomas.
The value of the f parameter, i.e. the perfusion fraction calculated with IVIM analysis, was significantly higher for the high-grade than for the low-grade lesions. In particular, the mean value of f of highgrade lesions is equal to 0.146 (median 0.15) with a standard deviation (SD) of AE0.037, while the mean value of f of low-grade lesions is 0.078 (median 0.08) but with a SD of AE0.013 (p < 0.0009 with the MannWhitney one-tailed test) (Figure 1) .
The rCBV of high-grade lesions is 12.19 (median 11.6) with SD AE 5.45 while that of low-grade lesions is 4.03 (median 4.05) with SD AE 0.82; the Mann-Whitney onetailed test shows a highly significant difference between the two groups of low and high grade lesions (p < 0.0005).
The SD of the f-IVIM for the two groups of tumours, however, was not homogeneous, with a more than double amplitude for high-grade lesions compared to low-grade ones. Similarly, the SD of rCBV for the high-grade tumours was much higher than the SD of the low-grade lesions.
The correlation coefficient r (Pearson) was then calculated between the perfusion fraction f-IVIM and the value of rCBV; this coefficient is equal to 0.53 and is therefore indicative of a moderate correlation between these two variables.
Assuming also a cut-off of 0.09 for the f-IVIM, we observed a sensitivity of 95.45% and a specificity of 83.33% in differentiating between high and low grade tumour lesions using this particular method. In contrast, by establishing a cut-off higher than 4.87 for rCBV, the sensitivity and specificity of DSC-MRI in distinguishing between low and high grade lesions are 95.24% and 100% respectively (Figure 2 ).
Discussion
Our study has shown a statistically significant difference (p < 0.05) of the perfusion fraction f-IVIM between the low-grade and high-grade glioma groups, thus confirming the preliminary results reported in the very few articles available in the literature to date, which, additionally, are based on almost always numerically limited patient samples. [17] [18] [19] A study recently published by Chinese researchers and coordinated by Hu et al. has, however, shown that the values of f-IVIM for high-grade tumours are even lower than for low-grade ones, in sharp contrast to our observations and what has already been described in the literature. Even the absolute values of the perfusion fraction reported by Hu et al. are considerably higher than those observed by us. 20 In this respect, Hu et al. used, as the rationale for choosing the positioning of the region of interest, the highest cellularity areas identified by DWI, whereas in our study, as well as in those of Federau et al. and in those of Bisdas et al., the ROI was positioned taking into account the highest perfusion zone, qualitatively identifiable in the f-IVIM map. [17] [18] [19] Of particular interest is case number two, initially classified among tumour recurrences in the field of low-grade lesions. The histological analysis, performed at another hospital in 2011, identified the tumour as a Grade II oligoastrocytoma with the following genetic traits: isocitrate dehydrogenase (IDH) gene mutation, an unusually high Ki-67 proliferative index (40%) and absence of methylation, the latter being an uncommon finding in a low-grade oligodendroglioma. The followup MRI performed in July 2014 showed, in contrast to previous imaging investigations, a significant increase in the size of the residual tumour; the values of f-IVIM and rCBV calculated by localising the ROI in neoplastic areas were also particularly high, equal to 0.19 for IVIM and 17.18 for rCBV respectively, highly suggestive of malignancy. In view of the clinical/radiological picture, contrasting with the outcome of earlier pathological anatomy tests, the patient underwent surgical reintervention. The final diagnosis was grade III anaplastic oligodendroglioma, consistent with both f-IVIM and rCBV measured values (Figure 3) .
Other interesting cases are number three (anaplastic astrocytoma, Grade III) and number nine (multiform glioblastoma, Grade IV). The former case is an inoperable lesion in the right thalamic area, with an uncharacteristically low f-IVIM value of 0.6. The calculated rCBV within the lesion also showed low values, equal to 2.2, not suggestive of a high-grade lesion. Moreover, morphological imaging of the tumour showed no enhancement in the altered signal area. It therefore appears to be a false negative both in terms of IVIM and of DSC-MRI perfusion imaging. The reasons for this finding remain unclear. However, it is likely that the angiogenesis of the tumour might have been affected by the rapid growth of cancer cells, necrosis of the tumour and interstitial oedema due to increased vascular permeability, with resulting compression of small capillaries.
In the second patient, on the other hand, the value of f-IVIM calculated in the residual tumour in the left temporal and hippocampus areas was equal to 0.09, significantly deviating from the average of the highgrade lesions. However, in this case, MRI was performed two weeks after the conclusion of a 6000 cGy radiotherapy course, therefore, the reduced perfusion Linear regression between f-intravoxel incoherent motion (f-IVIM) (on the x axis) and relative cerebral blood volume (rCBV) (on the y axis). The r Pearson coefficient calculated between these two parameters shows just a moderate correlation. This reflects the different characteristics measured by these two perfusion parameters. f-IVIM measures microscopic molecular motion due to blood microcirculation in the capillaries, while CBV measures the attenuation effect of the signal due to the presence of the contrast agent within a capillary.
fraction may be ascribed to radiotherapy-induced effects.
In addition, because of the peculiar anatomical location of the residual tumour, the DSC-MRI did not provide significant information for rCBV calculation. With regard to the moderate correlation between the values of f-IVIM and those of rCBV detected with the Pearson test, this may be interpreted in the light of the different characteristics of these two perfusion parameters. The f-IVIM measures microscopic molecular motion due to blood microcirculation in the capillaries, while rCBV measures the attenuation effect of the signal due to the presence of the contrast agent within the capillary. Furthermore, the sequences used for the f-IVIM and the DSC-MRI are different (an SE sequence in the former case, and a gradient-echo in the latter case), with a different response to vessel size. Finally, the value of the perfusion fraction calculated with IVIM depends on the geometry of the micro-vascular structure; in tumours, however, this geometry can be severely altered and this may explain the mismatch between the different and not always correlated values obtained with the two techniques. 17, 21, 22 One problem encountered during the processing of the f-IVIM maps was the alteration of the signal induced by the areas containing CSF, by oedemigenous and/or necrotic areas and by haemorrhagic areas. In fact, they determine an abnormal increase in the perfusion fraction, either because of CSF flow in the ventricles and subarachnoid spaces, or due to the 'T2 shine through' effect, in the case of oedemigenous and/or necrotic areas.
Furthermore, IVIM is also sensitive to the presence of possible haemorrhagic areas because these areas alter normal tissue relaxation times, depending on the level of oxygenation of the extravasated material 23 ( Figure 4) .
A definitive solution to these problems is not yet available. In order to address them in our study we adopted a dual approach. The positioning of the ROI on f-IVIM maps was always done with the utmost care, including via reading other morphological MRI sequences, in order to avoid these possible sources of contamination of the values of f.
We also proceeded to setting up threshold values so that all of the perfusion fraction values f > 0.3 were reduced to zero as they are considered non-physiological. In this way, the necrotic/oedemigenous areas and fluid were at least partially deleted in the f-IVIM map, thus facilitating the positioning of the ROI ( Figure 5) .
The other notable aspect in the definition of the technical parameters for the acquisition of a correct IVIM sequence is the definition of a sufficient number of bvalues and their correct distribution. 24, 25 The few studies currently available show a high degree of variability in this field, ranging from a minimum of 4 to over 10 different b-values used.
24,26
Conclusions
The quantification of cerebral blood perfusion with current methods of investigation such as DSC-MRI, dynamic contrast enhanced (DCE)-MRI and arterial spin labelling (ASL) remains a challenge since it depends essentially on the correct determination of the arterial input factor (AIF) which is difficult to estimate accurately because of the contrast agent bolus delay and dispersion.
IVIM, however, despite the limitations described above, is confirmed to date as an alternative of major scientific interest, in that it does not require the use of a contrast agent and relies on the intrinsic properties of motion inside the capillaries of the spins, and therefore would, at least in theory, provide an accurate quantitative assessment of the tissue perfusion values. 27 In addition, IVIM enables the simultaneous acquisition of information on diffusion and on tumour microcirculation, without relying on an intravenous contrast medium, which is an undoubted advantage in patients with severely compromised renal function or with severe allergies to a contrast medium.
Finally, IVIM is more sensitive to incoherent motions that originate from small capillary vessels, while the DSC signal is contaminated by input from larger arteries and veins, which may result in an overestimation of the blood volume. 19 Although there are limitations due to the heterogeneity of the sample considered by our study and artefacts caused by CSF in the maps of the perfusion fraction, IVIM has been shown to be an accurate non-invasive radiological biomarker, useful to distinguish between low and high grade glial tumours.
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